About Contact Us Careers

Thyroid Cancer Treatment Market Size & Share, by Treatment Type (Surgery, Iodine Therapy, External Radiotherapy, Thyroxin Treatment, Chemotherapy, Drugs); Cancer Type (Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer, Anaplastic Thyroid Cancer, Hurthle Cell Cancer); End-User (Hospitals & Clinics, Cancer Diagnostic Centres, Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 2997
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Thyroid Cancer Treatment Market size is projected to grow at substantial growth rate during the forecast period i.e., between 2025-2037.

The increasing prevalence of thyroid cancer globally, along with the growing investment in the healthcare expenditure are expected to fuel the development of this market. The growth of the market can also be attributed to factors such as the increasing geriatric population and the rising middle-class population in the emerging economies on a global level. According to the data collected from the United Nations Department of Economic and Social Affairs, in 2020, the estimated elderly population aged above 65 accounted for 727 million and by 2050 the number is expected to get double to approximately 1,500 million.

Global-Thyroid-Cancer-Treatment-Market-Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

Growth Drivers

  • Rising Prevalence of Thyroid Cancer
  • Increasing Geriatric Population in the World

Challenges

  • High Cost of Diagnosis
  • Lack of Awareness in the Under-Developed and Developing Countries

Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Thyroid Cancer Treatment Segmentation

The market is segmented based on treatment type into surgery, iodine therapy, external radiotherapy, thyroxin treatment, chemotherapy, and drugs, out of which, the drug segment is anticipated to grab the largest share by the end of 2021 on account of increased approval of thyroid cancer drugs in the market. Moreover, increasing initiative by the major players to develop better drugs in the global market is also projected to contribute to the growth of the segment during the forecast period.

On the basis of cancer type, the papillary thyroid cancer segment in the global thyroid cancer treatment market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that patients has witnessed high recovery rate in papillary thyroid cancer treatment. As a result, a considerable portion of the population with papillary thyroid cancer on a global level is expected to drive the growth of the market over the forecast period.

Based on end-user, the cancer diagnostic centres segment held the largest share in the market on the back of increasing investment in research & development studies and growing concern and awareness for thyroid cancer treatment.

Our in-depth analysis of the global market includes the following segments:

           By Treatment Type
  • Surgery
  • Iodine Therapy
  • External Radiotherapy
  • Thyroxin Treatment, Chemotherapy
  • Drugs
    • Ipilimumab
    • Nivolumab
    • Vandetanib
    • Others

             By Cancer Type
  • Papillary Thyroid Cancer
  • Follicular Thyroid Cancer
  • Medullary Thyroid Cancer
  • Anaplastic Thyroid Cancer
  • Hurthle Cell Cancer

 

 

           By End-user
  • Hospital & Clinics
  • Cancer Diagnostic Centers
  • Research Institutes
  • Others
 

 

 

Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Thyroid Cancer Treatment Industry - Regional Synopsis

Geographically, the thyroid cancer treatment market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific industry is set to dominate majority revenue share by 2037, owing to increasing elderly population, and rising investment in R&D for the innovation of new drugs and techniques for thyroid cancer treatment in the region. Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue, owing to the growing healthcare investment, accompanied by the presence of leading healthcare service providers, and the increasing number of cancer patients in the region. Along with this, the countries in North America such as the United States is promoting cancer care for cancer patients, which is also expected to contribute to the market growth in the region. According to the report published by the National Cancer Institute, in 2020, 1.8 million new cancer cases were registered in the United States. Such increasing rate of cancer is further expected to drive the demand for thyroid cancer treatment products in the North American countries. Alternatively, the market in Europe is also anticipated to occupy a significant share in the global market on account of its proven success in terms of technology development and a high prevalence of cancer in the region. As per the analysis of the European Society for Medical Oncology, 2.7 million new cancer cases were registered in the European Union, with 1.3 million deaths in 2020.

Thyroid-Cancer-Treatment-Market-Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Companies Dominating the Thyroid Cancer Treatment Landscape

    • Sanofi S.A.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Exelixis, Inc.
    • Medtronic plc
    • Eisai Co., Ltd. 
    • Bayer AG
    • Novartis International AG
    • Pfizer Inc.
    • Mylan N.V.
    • Bristol Myers Squibb
  • Report ID: 2997
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

Thyroid Cancer Treatment Market size is projected to grow at substantial growth rate during the forecast period i.e., between 2025-2037.

Rising prevalence of thyroid cancer and increasing elderly population will drive the market growth.

Asia Pacific industry is set to dominate majority revenue share by 2037, owing to increasing elderly population, and rising investment in R&D for the innovation of new drugs and techniques for thyroid cancer treatment in the region.

The major players in the market are Sanofi S.A., Exelixis, Inc., Medtronic plc, Eisai Co., Ltd., Bayer AG, Novartis International AG, Pfizer Inc., Mylan N.V., Bristol Myers Squibbothers, and others.

Thyroid Cancer Treatment Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos